Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-21 · accession 0001600620-25-000110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | 2025-11-21 | AUPH | Bailey Jeffrey Allen | Dir | F - Tax | $15.68 | -2,716 | 22.8K | -11% | -$42.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-11-21 | F | D | 2,716 | $15.68 | 22,775 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |